Home » Topics » Regulatory

Regulatory
RSS

FDA approves Yondelis for liposarcoma and leiomyosarcoma

Oct. 26, 2015

FDA approves Merrimack's liposomal irinotecan for pancreatic cancer

Oct. 23, 2015

FDA approves Veltassa for hyperkalemia

Oct. 22, 2015

FDA approves Coagadex for hereditary factor X deficiency

Oct. 21, 2015

FDA approves Praxbind as dabigatran reversal agent

Oct. 19, 2015

FDA approves Aristada for schizophrenia

Oct. 6, 2015

Maruho's Zebiax approved in Japan for bacterial skin infections

Sep. 30, 2015

Shionogi's Mulpleta approved in Japan for thrombocytopenia

Sep. 29, 2015

GlaxoSmithKline's Zagallo receives approval in Japan

Sep. 29, 2015

Japan first country to approve omarigliptin

Sep. 28, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...